Marijn E. Dekkers - Jun 10, 2021 Form 4 Insider Report for Quantum-Si Inc (QSI)

Role
Director
Signature
/s/ Christian LaPointe, Ph.D., Attorney-in-Fact
Stock symbol
QSI
Transactions as of
Jun 10, 2021
Transactions value $
$5,000,000
Form type
4
Date filed
6/14/2021, 06:53 PM
Previous filing
Jun 8, 2021
Next filing
Sep 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QSI Class A Common Stock Award $5M +500K $10.00 500K Jun 10, 2021 By Novalis Lifesciences Investments I, LP F1, F2
transaction QSI Class A Common Stock Award +150K 150K Jun 10, 2021 Direct F3, F4
transaction QSI Class A Common Stock Award $0 +20.5K +13.67% $0.00 171K Jun 11, 2021 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), Novalis Lifesciences Investments I, LP ("Novalis") purchased 500,000 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger.
F2 Dr. Dekkers has sole voting and investment control over the shares held by Novalis.
F3 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 12 equal quarterly installments beginning on June 30, 2021, which vesting will be delayed to the extent the Issuer has not filed a Form S-8 registering such shares by the applicable vesting date, subject to Dr. Dekkers's continued service through the applicable vesting date.
F4 Received in connection with the Merger in exchange for 188,089 RSUs of Qunatum-Si.
F5 Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on June 11, 2022, subject to Dr. Dekkers's continued service through the applicable vesting date.